Page results
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
Critical care incorporates general adult intensive care, high-dependency, the Post-Anaesthetic Care Unit (PACU), critical care outreach and the Critical Care Follow-up Clinic.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
-
Info about our regular, online origami club for people under the care of UCLH for cancer or a blood condition
-
Dr Richard Sylvester is a consultant neurologist with an interest in traumatic brain injuries.
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
During winter, the cold weather can put people at higher risk of becoming unwell.
-
Providing expert care for tropical and infectious diseases. Our specialist team provides comprehensive diagnosis, treatment, and travel health services, including an emergency walk-in service for travellers returning from travel.
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
This service is part of Respond. We offer general paediatric clinic appointments at UCLH to children and young people seeking asylum and refugees. Children are seen by a dedicated team of paediatricians with expertise in asylum seeker and refugee healthcare, and trauma-informed care. This includes unaccompanied children seeking asylum-seeking children (UASC), in partnership with local children looked after health services.
File results
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm